Artículos de revistas sobre el tema "SA14-14-2 E"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "SA14-14-2 E".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Huang, Rong, Shengling Leng, Yalan Feng, Liping Tang, Lei Yuan y Jian Yang. "Chimeric Japanese Encephalitis Virus SA14/SA14-14-2 Was Virulence Attenuated and Protected the Challenge of Wild-Type Strain SA14". Canadian Journal of Infectious Diseases and Medical Microbiology 2019 (3 de marzo de 2019): 1–7. http://dx.doi.org/10.1155/2019/9179308.
Texto completoYe, Qing, Xiao-Feng Li, Hui Zhao, Shi-Hua Li, Yong-Qiang Deng, Rui-Yuan Cao, Ke-Yu Song et al. "A single nucleotide mutation in NS2A of Japanese encephalitis-live vaccine virus (SA14-14-2) ablates NS1’ formation and contributes to attenuation". Journal of General Virology 93, n.º 9 (1 de septiembre de 2012): 1959–64. http://dx.doi.org/10.1099/vir.0.043844-0.
Texto completoKhou, Cécile, Marco Aurelio Díaz-Salinas, Anaelle da Costa, Christophe Préhaud, Patricia Jeannin, Philippe V. Afonso, Marco Vignuzzi, Monique Lafon y Nathalie Pardigon. "Comparative analysis of neuroinvasion by Japanese encephalitis virulent and vaccine viral strains in an in vitro model of human blood-brain barrier". PLOS ONE 16, n.º 6 (4 de junio de 2021): e0252595. http://dx.doi.org/10.1371/journal.pone.0252595.
Texto completoGromowski, Gregory D., Cai-Yen Firestone y Stephen S. Whitehead. "Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice". Journal of Virology 89, n.º 12 (8 de abril de 2015): 6328–37. http://dx.doi.org/10.1128/jvi.00219-15.
Texto completoLi, Guohua, Xianyong Meng, Zhiguang Ren, Entao Li, Feihu Yan, Jing Liu, Ying Zhang et al. "Characteristics of Chimeric West Nile Virus Based on the Japanese Encephalitis Virus SA14-14-2 Backbone". Viruses 13, n.º 7 (29 de junio de 2021): 1262. http://dx.doi.org/10.3390/v13071262.
Texto completoLiu, Zheng-le, S. Hennessy, B. L. Strom, T. F. Tsai y S. B. Halstead. "Safety of live-attenuated Japanese encephalitis (JE) vaccine (SA14-14-2)". Journal of Clinical Epidemiology 50 (enero de 1997): S17. http://dx.doi.org/10.1016/s0895-4356(97)87218-6.
Texto completoYang, Dong, Xiao-Feng Li, Qing Ye, Hong-Jiang Wang, Yong-Qiang Deng, Shun-Ya Zhu, Yu Zhang, Shi-Hua Li y Cheng-Feng Qin. "Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2". Vaccine 32, n.º 23 (mayo de 2014): 2675–81. http://dx.doi.org/10.1016/j.vaccine.2014.03.074.
Texto completoLiu, Xinyu, Xin Zhao, Rui Na, Lili Li, Eberhard Warkentin, Jennifer Witt, Xu Lu et al. "The structure differences of Japanese encephalitis virus SA14 and SA14-14-2 E proteins elucidate the virulence attenuation mechanism". Protein & Cell 10, n.º 2 (11 de mayo de 2018): 149–53. http://dx.doi.org/10.1007/s13238-018-0551-6.
Texto completoAdetunji, Shakirat A., Dmitriy Smolensky, Dana N. Mitzel, Jeana L. Owens, Carol G. Chitko-McKown, Natalia Cernicchiaro y Leela E. Noronha. "In Vitro Infection Dynamics of Japanese Encephalitis Virus in Established Porcine Cell Lines". Pathogens 10, n.º 11 (12 de noviembre de 2021): 1468. http://dx.doi.org/10.3390/pathogens10111468.
Texto completoArroyo, Juan, Farshad Guirakhoo, Sabine Fenner, Zhen-Xi Zhang, Thomas P. Monath y Thomas J. Chambers. "Molecular Basis for Attenuation of Neurovirulence of a Yellow Fever Virus/Japanese Encephalitis Virus Chimera Vaccine (ChimeriVax-JE)". Journal of Virology 75, n.º 2 (15 de enero de 2001): 934–42. http://dx.doi.org/10.1128/jvi.75.2.934-942.2001.
Texto completoXin, Yu Yong, Ao Jian, Guo Yu Peng, Li Ho Min y Zhang Guo Ming. "Safety of a Live-Attenuated Japanese Encephalitis Virus Vaccine (SA14-14-2) for Children". American Journal of Tropical Medicine and Hygiene 39, n.º 2 (1 de agosto de 1988): 214–17. http://dx.doi.org/10.4269/ajtmh.1988.39.214.
Texto completoHennessy, S., B. L. Strom, W. B. Bilker, L. Zhengle, W. Chao-Min, L. Hui-Lian, W. Tai-Xiang et al. "Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study". Lancet 347, n.º 9015 (junio de 1996): 1583–86. http://dx.doi.org/10.1016/s0140-6736(96)91075-2.
Texto completoLi, Guohua, Hongli Jin, Xin Nie, Yongkun Zhao, Na Feng, Zongxi Cao, Shuyi Tan et al. "Development of a reverse genetics system for Japanese encephalitis virus strain SA14-14-2". Virus Genes 55, n.º 4 (3 de junio de 2019): 550–56. http://dx.doi.org/10.1007/s11262-019-01674-y.
Texto completoLi, Xiao-Feng, Wei Zhao, Fang Lin, Qing Ye, Hong-Jiang Wang, Dong Yang, Shi-Hua Li et al. "Development of chimaeric West Nile virus attenuated vaccine candidate based on the Japanese encephalitis vaccine strain SA14-14-2". Journal of General Virology 94, n.º 12 (1 de diciembre de 2013): 2700–2709. http://dx.doi.org/10.1099/vir.0.059436-0.
Texto completoSohn, Young Mo, Min Soo Park, Hye Ok Rho, Laura J. Chandler, Robert E. Shope y Theodore F. Tsai. "Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants". Vaccine 17, n.º 18 (mayo de 1999): 2259–64. http://dx.doi.org/10.1016/s0264-410x(99)00006-7.
Texto completoLiu, Xinyu, Danhua Zhao, Lili Jia, Hongshan Xu, Rui Na, Yonghong Ge, Shaoxiang Liu, Yongxin Yu y Yuhua Li. "Genetic and neuroattenuation phenotypic characteristics and their stabilities of SA14-14-2 vaccine seed virus". Vaccine 36, n.º 31 (julio de 2018): 4650–56. http://dx.doi.org/10.1016/j.vaccine.2018.06.040.
Texto completoHong, Sun Pyo, Wang-Don Yoo, Robert Putnak, Kenneth H. Eckels, Hyune Mo Rho y Soo-Ok Kim. "Nucleotide Sequence of Envelope Protein of Japanese Encephalitis Virus SA14-14-2 Adapted to Vero Cells". DNA Sequence 12, n.º 5-6 (enero de 2001): 437–42. http://dx.doi.org/10.3109/10425170109084471.
Texto completoLi, Shi-Hua, Xiao-Feng Li, Hui Zhao, Yong-Qiang Deng, Xue-Dong Yu, Shun-Ya Zhu, Tao Jiang, Qing Ye, E.-De Qin y Cheng-Feng Qin. "Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2". Virology Journal 10, n.º 1 (2013): 64. http://dx.doi.org/10.1186/1743-422x-10-64.
Texto completoChambers, Thomas J., Ann Nestorowicz, Peter W. Mason y Charles M. Rice. "Yellow Fever/Japanese Encephalitis Chimeric Viruses: Construction and Biological Properties". Journal of Virology 73, n.º 4 (1 de abril de 1999): 3095–101. http://dx.doi.org/10.1128/jvi.73.4.3095-3101.1999.
Texto completoErra, Elina O. y Anu Kantele. "The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis". Expert Review of Vaccines 14, n.º 9 (10 de julio de 2015): 1167–79. http://dx.doi.org/10.1586/14760584.2015.1061939.
Texto completoSohn, Young Mo. "Primary and Booster Immune Responses to Live Attenuated SA14-14-2 Japanease Encephalitis Vaccine in Korean Infants". Korean Journal of Pediatric Infectious Diseases 5, n.º 1 (1998): 67. http://dx.doi.org/10.14776/kjpid.1998.5.1.67.
Texto completoYu, Yongxin. "Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities". Vaccine 28, n.º 21 (mayo de 2010): 3635–41. http://dx.doi.org/10.1016/j.vaccine.2010.02.105.
Texto completoYun, Sang-Im, Byung-Hak Song, Irina A. Polejaeva, Christopher J. Davies, Kenneth L. White y Young-Min Lee. "Comparison of the live-attenuated Japanese encephalitis vaccine SA14 -14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo". Journal of General Virology 97, n.º 10 (13 de octubre de 2016): 2575–91. http://dx.doi.org/10.1099/jgv.0.000574.
Texto completoWang, Ran, Meng Zhang, Linlin Zhang, Mengjia Liu, Chao Shan, Jing An y Zhengde Xie. "Japanese Encephalitis Vaccine Generates Cross-Reactive Memory T Cell Responses to Zika Virus in Humans". Journal of Tropical Medicine 2022 (19 de noviembre de 2022): 1–10. http://dx.doi.org/10.1155/2022/8379286.
Texto completoMonath, T. P., I. Levenbook, K. Soike, Z. X. Zhang, M. Ratterree, K. Draper, A. D. T. Barrett et al. "Chimeric Yellow Fever Virus 17D-Japanese Encephalitis Virus Vaccine: Dose-Response Effectiveness and Extended Safety Testing in Rhesus Monkeys". Journal of Virology 74, n.º 4 (15 de febrero de 2000): 1742–51. http://dx.doi.org/10.1128/jvi.74.4.1742-1751.2000.
Texto completoMonath, Thomas P., Juan Arroyo, Inessa Levenbook, Zhen-Xi Zhang, John Catalan, Ken Draper y Farshad Guirakhoo. "Single Mutation in the Flavivirus Envelope Protein Hinge Region Increases Neurovirulence for Mice and Monkeys but Decreases Viscerotropism for Monkeys: Relevance to Development and Safety Testing of Live, Attenuated Vaccines". Journal of Virology 76, n.º 4 (15 de febrero de 2002): 1932–43. http://dx.doi.org/10.1128/jvi.76.4.1932-1943.2002.
Texto completoYang, Jian, Huiqiang Yang, Zhushi Li, Wei Wang, Hua Lin, Lina Liu, Qianzhi Ni et al. "Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain". Viruses 9, n.º 1 (21 de enero de 2017): 20. http://dx.doi.org/10.3390/v9010020.
Texto completoTsai, T. F., Yu Yong‐Xin, Jia Li Li, Ravithat Putvatana, Zhang Ran, Wang Shougui y Scott B. Halstead. "Immunogenicity of Live Attenuated SA14–14–2 Japanese Encephalitis Vaccine—A Comparison of 1–and 3‐Month Immunization Schedules". Journal of Infectious Diseases 177, n.º 1 (enero de 1998): 221–23. http://dx.doi.org/10.1086/517358.
Texto completoB G, Ranganath. "Incidence of Adverse Events Following Immunization With SA14-14-2 Japanese Encephalitis Vaccine Among Children of 6 to 10Years In Kolar,India". JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES 01, n.º 2 (15 de junio de 2011): 49–54. http://dx.doi.org/10.58739/jcbs/v01i2.2.
Texto completoFeroldi, Emmanuel, Chitsanu Pancharoen, Pope Kosalaraksa, Kulkanya Chokephaibulkit, Mark Boaz, Claude Meric, Yanee Hutagalung y Alain Bouckenooghe. "Primary Immunization of Infants and Toddlers in Thailand with Japanese Encephalitis Chimeric Virus Vaccine in Comparison with SA14-14-2". Pediatric Infectious Disease Journal 33, n.º 6 (junio de 2014): 643–49. http://dx.doi.org/10.1097/inf.0000000000000276.
Texto completoYang, Huan, Fengming Fan, Lina Liu, Jie Liu, Yan Sun, Anping Xie, Xiaoling Shi et al. "A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain)". Vaccine 38, n.º 11 (marzo de 2020): 2636–42. http://dx.doi.org/10.1016/j.vaccine.2020.01.005.
Texto completoXu, Gaoyuan, Xiaojuan Xu, Zili Li, Qigai He, Bin Wu, Shengfu Sun y Huanchun Chen. "Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity". Vaccine 22, n.º 15-16 (mayo de 2004): 1846–53. http://dx.doi.org/10.1016/j.vaccine.2003.09.015.
Texto completoLiu, Zheng‐Le, Sean Hennessy, Brian L. Strom, Theodore F. Tsai, Chao‐Min Wan, Sheng‐Cai Tang, Cheng‐Fa Xiang et al. "Short‐Term Safety of Live Attenuated Japanese Encephalitis Vaccine (SA14–14–2): Results of a Randomized Trial with 26,239 Subjects". Journal of Infectious Diseases 176, n.º 5 (noviembre de 1997): 1366–69. http://dx.doi.org/10.1086/517323.
Texto completoChambers, Thomas J., Deborah A. Droll, Xiaoshan Jiang, William S. M. Wold y Janice A. Nickells. "JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: Biological properties in the mouse model of neuroinvasive disease". Virology 366, n.º 1 (septiembre de 2007): 51–61. http://dx.doi.org/10.1016/j.virol.2007.04.016.
Texto completoLiu, Xinyu, Yongxin Yu, Maoguang Li, Guodong Liang, Huanyu Wang, Lili Jia y Guanmu Dong. "Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China". Vaccine 29, n.º 11 (marzo de 2011): 2127–30. http://dx.doi.org/10.1016/j.vaccine.2010.12.108.
Texto completoSong, Byung-Hak, Gil-Nam Yun, Jin-Kyoung Kim, Sang-Im Yun y Young-Min Lee. "Biological and genetic properties of SA14-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans". Journal of Microbiology 50, n.º 4 (agosto de 2012): 698–706. http://dx.doi.org/10.1007/s12275-012-2336-6.
Texto completoWang, Hong-Jiang, Long Liu, Xiao-Feng Li, Qing Ye, Yong-Qiang Deng, E.-De Qin y Cheng-Feng Qin. "In vitro and in vivo characterization of chimeric duck Tembusu virus based on Japanese encephalitis live vaccine strain SA14-14-2". Journal of General Virology 97, n.º 7 (1 de julio de 2016): 1551–56. http://dx.doi.org/10.1099/jgv.0.000486.
Texto completoYang, Huiqiang, Zhushi Li, Hua Lin, Wei Wang, Jian Yang, Lina Liu, Xianwu Zeng, Yonglin Wu, Yongxin Yu y Yuhua Li. "A novel dengue virus serotype 1 vaccine candidate based on Japanese encephalitis virus vaccine strain SA14-14-2 as the backbone". Archives of Virology 161, n.º 6 (15 de marzo de 2016): 1517–26. http://dx.doi.org/10.1007/s00705-016-2817-8.
Texto completoNikam, Bhushan Sanjay, Anurag kalia, Suvechchha Pandit y Nimesh Gupta. "Ablation of regulatory T cells lead to compromised quality of humoral immunity to SA14-14-2 live attenuated Japanese encephalitis vaccine". Journal of Immunology 210, n.º 1_Supplement (1 de mayo de 2023): 158.02. http://dx.doi.org/10.4049/jimmunol.210.supp.158.02.
Texto completoTurtle, Lance, Filippo Tatullo, Tanushka Bali, Vasanthapuram Ravi, Mohammed Soni, Sajesh Chan, Savita Chib et al. "Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area". PLOS Neglected Tropical Diseases 11, n.º 1 (30 de enero de 2017): e0005263. http://dx.doi.org/10.1371/journal.pntd.0005263.
Texto completoNath, Barnali, Ashutosh Gupta, Siraj A. Khan y Sachin Kumar. "Enhanced cytopathic effect of Japanese encephalitis virus strain SA14-14-2: Probable association of mutation in amino acid of its envelope protein". Microbial Pathogenesis 111 (octubre de 2017): 187–92. http://dx.doi.org/10.1016/j.micpath.2017.08.046.
Texto completoSricharoenchai, Sirintip, Keswadee Lapphra, Sunate Chuenkitmongkol, Wanatpreeya Phongsamart, Alain Bouckenooghe, Orasri Wittawatmongkol, Supattra Rungmaitree y Kulkanya Chokephaibulkit. "Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination With Live Attenuated SA14-14-2 Vaccine". Pediatric Infectious Disease Journal 36, n.º 2 (febrero de 2017): e45-e47. http://dx.doi.org/10.1097/inf.0000000000001395.
Texto completoLi, Zhushi, Huiqiang Yang, Jian Yang, Hua Lin, Wei Wang, Lina Liu, Yu Zhao et al. "Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone". Virus Research 191 (octubre de 2014): 10–20. http://dx.doi.org/10.1016/j.virusres.2014.07.017.
Texto completoJanewongwirot, Pakpoom, Thanyawee Puthanakit, Suvaporn Anugulruengkitt, Watsamon Jantarabenjakul, Chayapa Phasomsap, Sompong Chumket, Sutee Yoksan y Chitsanu Pancharoen. "Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children". Vaccine 34, n.º 44 (octubre de 2016): 5279–83. http://dx.doi.org/10.1016/j.vaccine.2016.09.005.
Texto completoWang, Ran, Dongying Fan, Lei Wang, Yueqi Li, Hongning Zhou, Na Gao y Jing An. "Neutralizing antibody rather than cellular immune response is maintained for nearly 20 years among Japanese encephalitis SA14-14-2 vaccinees in an endemic setting". Infection, Genetics and Evolution 85 (noviembre de 2020): 104476. http://dx.doi.org/10.1016/j.meegid.2020.104476.
Texto completoYamshchikov, Vladimir, Marina Manuvakhova y Efrain Rodriguez. "Development of a human live attenuated West Nile infectious DNA vaccine: Suitability of attenuating mutations found in SA14-14-2 for WN vaccine design". Virology 487 (enero de 2016): 198–206. http://dx.doi.org/10.1016/j.virol.2015.10.015.
Texto completoWang, Ran, Zida Zhen, Lance Turtle, Baohua Hou, Yueqi Li, Na Wu, Na Gao, Dongying Fan, Hui Chen y Jing An. "T cell immunity rather than antibody mediates cross-protection against Zika virus infection conferred by a live attenuated Japanese encephalitis SA14-14-2 vaccine". Applied Microbiology and Biotechnology 104, n.º 15 (15 de junio de 2020): 6779–89. http://dx.doi.org/10.1007/s00253-020-10710-z.
Texto completoZheng, Xiaoyan, Xiaozheng Yu, Yan Wang, Min Cui, Ran Wang y Chenghong Yin. "Immune responses and protective effects against Japanese encephalitis induced by a DNA vaccine encoding the prM/E proteins of the attenuated SA14-14-2 strain". Infection, Genetics and Evolution 85 (noviembre de 2020): 104443. http://dx.doi.org/10.1016/j.meegid.2020.104443.
Texto completoCalvert, Amanda E., Kandice L. Dixon, Mark J. Delorey, Carol D. Blair y John T. Roehrig. "Development of a small animal peripheral challenge model of Japanese encephalitis virus using interferon deficient AG129 mice and the SA14-14-2 vaccine virus strain". Vaccine 32, n.º 2 (enero de 2014): 258–64. http://dx.doi.org/10.1016/j.vaccine.2013.11.016.
Texto completoWills, Mark R., Bijon K. Sil, Jing X. Cao, Y. X. Yu y Alan D. T. Barrett. "Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: a comparison with isolates of the virus covering a wide geographic area". Vaccine 10, n.º 12 (enero de 1992): 861–72. http://dx.doi.org/10.1016/0264-410x(92)90051-k.
Texto completo